About the journal
Liver Cancer is an open-access journal published by Karger Publishers in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,490 CHF. Declared review time at DOAJ: 23 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Karger Publishers
- ISSN
- 2235-1795 · 1664-5553
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 3,490 CHF
- Articles in DOAJ
- 388
- Declared review time
- 23 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.karger.com/lic
Index listings
- DOAJ · 2020-03-16
- Indexing
- DOAJ
- APC
- 3,490 CHF
- Declared review time (DOAJ)
- 23 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
388
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
23weeks
Works in OpenAlex
1050
Last recorded publication year
2026
h-index
81
i10-index
433
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2024-11-09
- Added to DOAJ
- 2020-03-16
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- PMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- Portico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 85%
- ORCID iDs in current deposits
- 70%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101597993
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Legal and Regulatory Analysis
- Legal and Regulatory Analysis
Show all subjects (50)
- Linguistic, Cultural, and Literary Studies
- Military Technology and Strategies
- Military Technology and Strategies
- Linguistic, Cultural, and Literary Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Mechanisms and Therapy
- Cancer Mechanisms and Therapy
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Hepatitis B Virus Studies
- Hepatitis B Virus Studies
- Organ Transplantation Techniques and Outcomes
- Organ Transplantation Techniques and Outcomes
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Liver physiology and pathology
- Liver physiology and pathology
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- Liver Disease and Transplantation
- Liver Disease and Transplantation
- Physics and Engineering Research Articles
- Physics and Engineering Research Articles
- Hepatitis C virus research
- Colorectal Cancer Treatments and Studies
- Cancer, Hypoxia, and Metabolism
- Colorectal Cancer Treatments and Studies
- Hepatitis C virus research
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Gallbladder and Bile Duct Disorders
- Gallbladder and Bile Duct Disorders
- Cancer, Lipids, and Metabolism
- MRI in cancer diagnosis
- MRI in cancer diagnosis
- Inflammatory Biomarkers in Disease Prognosis
- Inflammatory Biomarkers in Disease Prognosis
- Renal cell carcinoma treatment
- Radiomics and Machine Learning in Medical Imaging
- Renal cell carcinoma treatment
- Radiomics and Machine Learning in Medical Imaging
Keywords (DOAJ)
- gastroenterology
- oncology
- hepatology
- liver
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ